跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 338,538 条关于
“primary immunoglobulin A nephropathy”
全部
338,538
临床试验
287,957
药物
5,851
机构
4,016
资讯
40,714
5个月前
Calliditas Therapeutics Presents New NefIgArd Trial Data Supporting Nefecon's Gut-Targeted Mechanism in IgA Nephropathy
去年
Taiwan TFDA Approves Nefecon for Primary IgA Nephropathy Treatment
9个月前
FDA Grants Accelerated Approval to Otsuka's Voyxact for IgA Nephropathy, First APRIL-Targeting Therapy
2年前
FDA Grants Accelerated Approval to Novartis' Fabhalta (Iptacopan) for IgA Nephropathy
去年
Hong Kong Approves Four New Drugs Under Accelerated "1+" Mechanism, Including IgA Nephropathy Treatment
去年
NEFECON Receives Full NMPA Approval for IgA Nephropathy Treatment in China, Removing Proteinuria Restrictions
2年前
FDA Grants Full Approval to Travere's Filspari for IgA Nephropathy
去年
Travere Therapeutics Plans sNDA Submission for FILSPARI to Treat Rare Kidney Disease FSGS
去年
Novartis' Fabhalta Shows Promise in PNH Patients Switching from Anti-C5 Therapies
2个月前
Viatris Reports Positive Phase 3 Results for VR-205 in Japanese Adults with IgA Nephropathy, Targets 2026 NDA Submission
第 1 页,共 4072 页
上一页
下一页